Skip to main content

Education

  • Doctor (MD) at the Faculty of Medicine, University of Oslo (1996)
  • Doctoral degree (PhD) at the University of Oslo (2011)

Score

  • Senior physician in rheumatology, Diakonhjemmet hospital
  • Senior researcher, Clinic for rheumatology, outpatient clinic and research, Diakonhjemmet hospital
  • Professor, section for public health, Innlandet University College

Field of interest

  • Epidemiology, register data with a focus on comorbidities within inflammatory joint diseases and health economics
  • Non-medicinal intervention research with the development of innovative digital tools for pre-treatment and monitoring
  • Chronic pain conditions
  • Biomarkers as outcome and surrogate marker for comorbidities

Other

  • Co-leader work package 6 in REMEDY (Long-term follow-up)

Email

This email address is being protected from spambots. You need JavaScript enabled to view it.

Telephone

visiting address

Diakonhjemmet hospital
Diakonveien 12
0370 Oslo

Postal address

Diakohjemmet hospital
PO Box 23 Vinderen
0319 Oslo

Projects

WP6 - Dechiphering long-term outcomes

NOECON

Health economics in the treatment of inflammatory arthritis diseases

Project Manager:
Sell ​​Aarrestad Provan
WP6 - Dechiphering long-term outcomes

NOR-DMARD

The Norwegian register for antirheumatic drugs

Project Manager:
Tore K. Kvien
WP2 - PPhenotyping for personalized medicine

Nor-vaC

Immunological response to COVID-19 vaccine in patients on immunosuppressive treatment

Project Manager:
Guro Løvik Goll
WP5 - Innovative approaches to remote care

ReMonit

Digital home follow-up of patients with spondyloarthritis

Project Manager:
Nina Østerås
WP7 - Empowering the individual

KICK

SPondylaritis Condition

Project Manager:
Sell ​​Aarrestad Provan
WP1 - Optimized medical interventions

SQUEEZE

Maximizing the effect of prescription drugs in rheumatoid arthritis 

Project Manager:
Espen A. Haavardsholm

Publications

Publications taken from the National Science Archive (NVA):

Participatory Development of a Virtual Reality Exercise Program for People with Chronic Pain

Sella Aarrestad Provan, Giovanna Calogiuri, Sigbjørn Litleskare, Linda Røset, Henning Pettersen, Ole E. Flaten


Games for Health Journal

2024

Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study

Hassen Kared, Ingrid Jyssum, Amin Alirezaylavasani, Ingrid Marie Egner, Trung The Tran, Lisa Tietze


Frontiers in Immunology

2024

A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study

Sella Aarrestad Provan, F. Ahlfors, Gunnstein Bakland, Yi Hu, EK Kristianslund, Eirik Ikdahl


Scandinavian Journal of Rheumatology

2024

Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

Sara Nysom Christiansen, Simon Horskjær Rasmussen, Marion Pons, Brigitte Michelsen, Bente Glintborg, Bjorn Gudbjornsson


Seminars in Arthritis & Rheumatism

2024

Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration

Celina K. Gehringer, Glen P. Martin, Kimme L. Hyrich, Suzanne MM Verstappen, Joseph Sexton, Eirik Kristianslund


Journal of Clinical Epidemiology

2024

Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study

Hilde Sofie Sager Ørbo, Kristin Reine Hammersbøen, Joseph Sexton, Ingrid Jyssum, Anne Therese Tveter, Ingrid Egeland Christensen


RMD Open

2024

Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial

Inger Jorid Berg, Anne Therese Tveter, Gunnstein Bakland, Sarah Hakim, Eirik Kristianslund, Siri Lillegraven


JMIR Research Protocols

2023

Definition of rheumatoid arthritis flare based on SDAI and CDAI

Victoria Konzett, Andreas Kerschbaumer, Josef S. Smolen, Eirik Klami Kristianslund, Sella Aarrestad Provan, Tore Kristian Aaserud Kvien


Annals of the Rheumatic Diseases

2023

Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism in patients with inflammatory joint disease—results from the nationwide Norwegian Cardio-rheuma registry

Eirik Ikdahl, Silvia Christin Hellerud Rollefstad, Amirhossein Kazemi, Sella Aarrestad Provan, Trine-Lise Larsen, Anne Grete Semb


European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy

2023

Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study

Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Sella Aarrestad Provan, Tore Kristian Aaserud Kvien, Espen A. Haavardsholm


Rheumatology

2023

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Bente Glintborg, Daniela Di Giuseppe, Johan K. Wallman, Sella Aarrestad Provan, Dan Nordström, Anna-Mari Hokkanen


Rheumatology

2023

Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022

Sigrid Reppe Moe, Hilde Haukeland, Cathrine Brunborg, Antonela Botea, Nenad Damjanic, Gro Årthun Wivestad


Rheumatology

2023

How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway

Bénédicte Delcoigne, Sella Aarrestad Provan, Eirik Kristianslund, Johan Askling, Lotta Ljung


European journal of internal medicine

2023

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Bente Glintborg, Daniela Di Giuseppe, Johan Karlsson Wallman, Dan C Nordström, Bjorn Gudbjornsson, Merete Lund Hetland


Annals of the Rheumatic Diseases

2023

Cardiovascular organ damage in relation to hypertension status in patients with ankylosing spondylitis

Gyda Ullensvang, Ester Anne Kringeland, Eirik Ikdahl, Sella Aarrestad Provan, Inger Jorid Berg, Silvia Christin Hellerud Rollefstad


Blood Pressure

2023

Exposure to specific tumor necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

Benedicte Delcoigne, Tine Iskov Kopp, Elizabeth V. Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas


RMD Open

2023

Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

Rene Lindholm Cordtz, Johan Askling, Benedicte Delcoigne, Karin E. Smedby, Eva Baecklund, Christine Ballegaard


RMD Open

2022

Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study

Kristin H. Bjørlykke, Hilde Sofie Sager Ørbo, Anne Therese Tveter, Ingrid Jyssum, Joseph Sexton, Trung Tran


The Lancet Rheumatology

2022

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy

Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Ingrid Egeland Christensen, Trung Tran


RMD Open

2022

Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration

Bénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, Daniela Di Giuseppe, Thomas Frisell, Bente Glintborg


Rheumatology

2022

The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study

Ingrid Egeland Christensen, Ingrid Jyssum, Anne Therese Tveter, Joseph Sexton, Trung Tran, Siri Mjaaland


BMC Medicine

2022

Implementation of recommendations in rheumatic and musculoskeletal diseases: Considerations for development and uptake

Estibaliz Loza, Loreto Carmona, Anthony Woolf, Bruno Fautrel, Delphine S Courvoisier, Suzanne Verstappen


Annals of the Rheumatic Diseases

2022

The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries

Daniela Di Giuseppe, Ulf Lindström, Kalle Aaltonen, Heikki Relas, Sella Aarrestad Provan, Bjorn Gudbjornsson


Rheumatology

2022

One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses

Bente Glintborg, Ulf Lindström, Daniela Di Giuseppe, Sella Aarrestad Provan, Bjorn Gudbjornsson, Merete Lund Hetland


Arthritis care & research

2022

Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy

Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Trung Tran, Joseph Sexton, Sella Aarrestad Provan


Arthritis & Rheumatology

2022

Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: Results from four Nordic countries

Benedicte Delcoigne, Lotta Ljung, Sella Aarrestad Provan, Bente Glintborg, Merete Lund Hetland, Kathrine Lederballe Grøn


Annals of the Rheumatic Diseases

2022

Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study

Ingrid Jyssum, Hassen Kared, Trung Tran, Anne Therese Tveter, Sella Aarrestad Provan, Joseph Sexton


The Lancet Rheumatology

2021

Use of video consultations in an outpatient rheumatology clinic

Anne Therese Tveter, Sella Aarrestad Provan, Ellen Moholt, Kjetil Bergsmark, Nina Østerås


Journal of the Norwegian Medical Association

2021

Effectiveness of a Second Biologic After Failure of a Non–tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis

Katerina Chatzidionysiou, Merete Lund Hetland, Thomas Frisell, Daniela Di Giuseppe, Karin Hellgren, Bente Glintborg


Journal of Rheumatology

2021

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumor necrosis factor inhibitors: data from register linkage of the NOR-DMARD study

Ingrid Egeland Christensen, Siri Lillegraven, Mielnik Pawel, Gunnstein Bakland, Liz Paucar Loli, Joseph Sexton


Annals of the Rheumatic Diseases

2021

Effects of a mindfulness-based and acceptance-based group program followed by physical activity for patients with fibromyalgia: a randomized controlled trial

Trond Haugmark, Kåre Birger Hagen, Sella Aarrestad Provan, Geir Smedslund, Heidi A Zangi


BMJ Open

2021

The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis

Sella A. Provan, Linda E. Dean, Gareth Jones, Gary J. Macfarlane


Rheumatology

2021

Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study

Karin Hellgren, Christine Ballegaard, Bénédicte Delcoigne, René Cordtz, Dan C. Nordström, Kalle Aaltonen


Rheumatology

2021

Trajectories of change in symptom severity in patients with fibromyalgia: exploratory analyzes of a randomized controlled trial

Trond Haugmark, Kåre Birger Hagen, Sella Aarrestad Provan, Joseph Sexton, Heidi Andersen Zangi


Rheumatology International

2021

Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: A Nordic population-based cohort study

Rebekka Lund Hansen, Tanja Schoedt Jørgensen, Lene Dreyer, Merete Lund Hetland, Bente Glintborg, Johan Askling


Rheumatology

2021

How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

Katerina Chatzidionysiou, Bénédicte Delcoigne, Thomas Frisell, Merete L. Hetland, Bente Glintborg, Lene Dreyer


RMD Open

2020

Comparison of treatment retention and response to secukinumab versus tumor necrosis factor inhibitors in psoriatic arthritis

Ulf Lindström, Bente Glintborg, Daniela Di Giuseppe, Tanja Schjødt Jørgensen, Bjorn Gudbjornsson, Kathrine Lederballe Grøn


Rheumatology

2020

High-Intensity Exercise Improves Fatigue, Sleep, and Mood in Patients With Axial Spondyloarthritis: Secondary Analysis of a Randomized Controlled Trial

Silje Halvorsen Sveaas, Hanne Dagfinrud, Inger Jorid Berg, Sella Aarrestad Provan, Melissa Woll Johansen, Elisabeth Alexandersen Pedersen


Physical Therapy

2020

Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapy

Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Till Uhlig, Hilde Berner Hammer


RMD Open

2020

Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis

Hilde Berner Hammer, Brigitte Michelsen, Joe Sexton, Till Uhlig, Sella Aarrestad Provan


Clinical Rheumatology

2020

Trends in All-Cause and Cardiovascular Mortality in Patients With Incident Rheumatoid Arthritis: A 20-year Follow-Up Matched Case-Cohort Study

Sella Aarrestad Provan, Siri Lillegraven, Joseph Sexton, Kristin Angel, Cathrine Austad, Espen A. Haavardsholm


Rheumatology

2019

Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naive patients with spondyloarthritis

Ulf Lindström, Bente Glintborg, Daniela Di Giuseppe, Dan C. Nordström, Sella Aarrestad Provan, Björn Gudbjörnsson


RMD Open

2019

Biomarkers of cardiovascular risk across phenotypes of osteoarthritis

Sella Aarrestad Provan, Silvia Christin Hellerud Rollefstad, Eirik Ikdahl, Alexander Mathiessen, Inger Jorid Berg, IB Wilkinson


Biomed Central Rheumatology

2019

Swollen, but not tender joints, are independently associated with ultrasound synovitis: Results from a longitudinal observational study of patients with established rheumatoid arthritis

Hilde Berner Hammer, Brigitte Michelsen, Joseph Sexton, Ida Kristin Haugen, Sella Aarrestad Provan, Espen A. Haavardsholm


Annals of the Rheumatic Diseases

2019

High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): A multicentre randomized trial of 100 patients

Silje Halvorsen Sveaas, Annelie Bilberg, Inger Jorid Berg, Sella Aarrestad Provan, Silvia Christin Hellerud Rollefstad, Anne Grete Semb


British Journal of Sports Medicine

2019

Fibromyalgia in patients with rheumatoid arthritis. A 10-year follow-up study, results from the Oslo Rheumatoid Arthritis Register

Sella Aarrestad Provan, Cathrine Austad, Vera Halsaa, Hilde Berner Hammer, Tore Kristian Kvien, Till Uhlig


Clinical and Experimental Rheumatology

2019

Osteoarthritis-Related Walking Disability and Arterial Stiffness: Results From a Cross-Sectional Study

Kenth-Louis Hansen Joseph, Kåre Birger Hagen, Anne Therese Tveter, Karin Magnusson, Sella Aarrestad Provan, Hanne Dagfinrud


Arthritis care & research

2019

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries

Bente Glintborg, Ulf Lindström, Kalle Aaltonen, Eirik Kristianslund, Björn Guðbjörnsson, Katerina Chatzidionysiou


Scandinavian Journal of Rheumatology

2018

Tender joint count may not reflect inflammatory activity in established rheumatoid arthritis patients: results from a longitudinal study

Hilde Berner Hammer, Brigitte Michelsen, Sella Aarrestad Provan, Joseph Sexton, Jon Lampa, Till Uhlig


Arthritis care & research

2018

Associations Between Cardiorespiratory Fitness and Arterial Stiffness in Ankylosing Spondylitis: A Cross-sectional Study

Inger Jorid Berg, Anne Grete Semb, Silje Halvorsen Sveaas, Camilla Fongen, Desirée van der Heijde, Tore Kristian Kvien


Journal of Rheumatology

2018

Effects of a community-based multicomponent rehabilitation program for patients with fibromyalgia: protocol for a randomized controlled trial

Trond Haugmark, Kåre Birger Hagen, Sella Aarrestad Provan, Elisebeth Bærheim, Heidi Andersen Zangi


BMJ Open

2018

Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example

Katerina Chatzidionysiou, Merete Lund Hetland, Thomas Frisell, Daniela Di Giuseppe, Karin Hellgren, Bente Glintborg


RMD Open

2018

Treating fatigue in rheumatoid arthritis: does patient age matter?

Till Uhlig, Sella Aarrestad Provan


Drugs & Aging

2018

Evidence of reduced parasympathetic autonomic regulation in inflammatory joint disease: A meta-analyses study

Sella Aarrestad Provan, Daniela Schäfer Olstad, Erik Ekker Solberg, Geir Smedslund, Hanne Dagfinrud


Seminars in Arthritis & Rheumatism

2017

Calcium supplementation and inflammation increase mortality in rheumatoid arthritis: A 15-year cohort study in 609 patients from the Oslo Rheumatoid Arthritis Register

Sella Aarrestad Provan, Inge Christoffer Olsen, Cathrine Austad, Glenn Haugeberg, Tore Kristian Kvien, Till Uhlig


Seminars in Arthritis & Rheumatism

2017

Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis

Eirik Ikdahl, Silvia Christin Hellerud Rollefstad, Grunde Wibetoe, Inge Christoffer Olsen, Inger Jorid Berg, Jonny Hisdal


Journal of Rheumatology

2016

CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: Results after 5-year follow-up

Inger Jorid Berg, Anne Grete Semb, Desirée van der Heijde, Tore Kristian Kvien, Inge Christoffer Olsen, Hanne Dagfinrud


Annals of the Rheumatic Diseases

2015

Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: A cross-sectional study

Inger Jorid Berg, Desirée van der Heijde, Hanne Dagfinrud, Ingebjørg Seljeflot, Inge Christoffer Olsen, Tore Kristian Kvien


Journal of Rheumatology

2015

The impact of newer biological disease modifying anti-rheumatic drugs on cardiovascular risk factors: A 12-month longitudinal study in rheumatoid arthritis patients treated with rituximab, abatacept and tociliziumab

Sella Aarrestad Provan, Inger Jorid Berg, Hilde Berner Hammer, Alexander Mathiessen, Tore Kristian Kvien, Anne Grete Semb


PLOS ONE

2015

Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: A cross-sectional comparative study

Silje Halvorsen Sveaas, Inger Jorid Berg, Sella Aarrestad Provan, Anne Grete Semb, Inge Christoffer Olsen, Thor Ueland


Scandinavian Journal of Rheumatology

2015

Efficacy of High Intensity Exercise on Disease Activity and Cardiovascular Risk in Active Axial Spondyloarthritis: A Randomized Controlled Pilot Study

Silje Halvorsen Sveaas, Inger Jorid Berg, Sella Aarrestad Provan, Anne Grete Semb, Kåre Birger Hagen, Nina Køpke Vøllestad


PLOS ONE

2014

Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: A cross-sectional study

Inger Jorid Berg, Anne Grete Semb, Desirée van der Heijde, Tore Kristian Kvien, Jonny Hisdal, Inge Christoffer Olsen


Seminars in Arthritis & Rheumatism

2014

Relationship between types of radiographic damage and disability in patients with rheumatoid arthritis in the EURIDISS cohort: a longitudinal study

Victoria Navarro-Compan, Robert Landewé, Sella Aarrestad Provan, Sigrid Ødegård, Till Uhlig, Tore Kristian Kvien


Rheumatology

2014

Hand, hip and knee osteoarthritis in a Norwegian population-based study - The MUST protocol

Nina Østerås, May Arna Risberg, Tore Kristian Kvien, Lars Engebretsen, Lars Nordsletten, Dag Bruusgaard


BMC Musculoskeletal Disorders

2013

Cardiorespiratory Fitness and Cardiovascular Risk in Patients With Ankylosing Spondylitis: A Cross-Sectional Comparative Study

Silje Halvorsen, Nina Køpke Vøllestad, Sella Aarrestad Provan, Anne Grete Semb, Désirée van der Heijde, Kåre Birger Hagen


Arthritis Care and Research

2013

Associations between APOE Genotypes and Disease Susceptibility, Joint Damage and Lipid Levels in Patients with Rheumatoid Arthritis

Marthe Thoresen Mæhlen, Sella Aarrestad Provan, Diederik PC de Rooy, Annette HM van der Helm-van Mil, Annemarie Krabben, Tore Saxne


PLOS ONE

2013

Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis

Anne Grete Semb, Silvia Christin Hellerud Rollefstad, Sella Aarrestad Provan, Tore Kristian Kvien, Einar Stranden, Inge Christoffer Olsen


Journal of Rheumatology

2013

The L-arginine/asymmetric dimethylarginine ratio is improved by anti-Tumor Necrosis Factor-alpha therapy in inflammatory arthropathies. Associations with aortic stiffness

Kristin Angel, Sella Aarrestad Provan, Petter Mowinckel, Ingebjørg Seljeflot, Tore Kristian Kvien, Dan Atar


Atherosclerosis

2012

Effect of 1-Year Anti-TNF-alpha Therapy on Aortic Stiffness, Carotid Atherosclerosis, and Calprotectin in Inflammatory Arthropathies: A Controlled Study

Kristin Angel, Sella Aarrestad Provan, Magne Kristoffer Fagerhol, Petter Mowinckel, Tore Kristian Kvien, Dan Atar


American Journal of Hypertension

2012

Physical Fitness in Patients With Ankylosing Spondylitis: Comparison With Population Controls

Silje Halvorsen, Nina Køpke Vøllestad, Camilla Fongen, Sella Aarrestad Provan, Anne Grete Semb, Kåre Birger Hagen


Physical Therapy

2012

High cardiorespiratory fitness is related to lower cardiovascular risk in patients with ankylosing spondylitis

Silje Halvorsen, Nina Køpke Vøllestad, Sella Aarrestad Provan, Anne Grete Semb, Désirée van der Heijde, Kåre Birger Hagen


Arthritis Care and Research

2012

Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study

Sella Aarrestad Provan, Anne Grete Semb, Jonny Hisdal, Einar Stranden, Stefan Agewall, Hanne Dagfinrud


Annals of the Rheumatic Diseases

2011

Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies

Kristin Angel, Sella Aarrestad Provan, Hilde Berner Hammer, Petter Mowinckel, Tore Kristian Kvien, Dan Atar


Fundamental & Clinical Pharmacology

2011

Early Prediction of Increased Arterial Stiffness in Patients with Chronic Inflammation: A 15-year Followup Study of 108 Patients with Rheumatoid Arthritis

Sella Aarrestad Provan, Kristin Angel, Anne Grete Semb, Petter Mowinckel, Stefan Agewall, Dan Atar


Journal of Rheumatology

2011

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

Mike JL Peters, Deborah PM Symmons, David McCarey, Ben AC Dijkmans, Paulo Nicola, Tore Kristian Kvien


Annals of the Rheumatic Diseases

2010

Changes in arterial stiffness during continued infliximab treatment in patients with inflammatory arthropathies

Kristin Angel, Sella Aarrestad Provan, Hilde Berner Hammer, Petter Mowinckel, Tore Kristian Kvien, Dan Atar


Fundamental & Clinical Pharmacology

2010

NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study

Sella Aarrestad Provan, Kristin Angel, Anne Grete Semb, Dan Atar, Tore Kristian Kvien


Annals of the Rheumatic Diseases

2010

Tumor Necrosis Factor-alpha Antagonists Improve Aortic Stiffness in Patients With Inflammatory Arthropathies A Controlled Study

Kristin Angel, Sella Aarrestad Provan, Hanne Løvdal Gulseth, Petter Mowinckel, Tore Kristian Kvien, Dan Atar


Hypertension

2010